A new Drosophila melanogaster research resource: CRISPR-induced mutations for clonal analysis of fourth chromosome genes is a dataset published in G3 Genes Genomes Genetics (2025). On theSindex it has a DataRank of 0.104, placing it in the top 77.8% of the data-sharing corpus. It has been cited 1 time. Its calibrated FAIR score is 29/100.
Ranks in the top 78% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
The headline score is computed from the scored criteria — the fact-shaped checks (a repository, an accession, a licence) that two independent models agree on. The advisory criteria below are real FAIR guidance but rest on judgment calls that models read differently, so they inform without moving the number.
No persistent identifier (DOI, Handle, ARK, URN, or repository accession) is given for the dataset; the article DOI is not the data's identifier.
RDA-F1-01D — FAIR Data Maturity Model: 'Data is identified by a persistent identifier' (priorit · RDA-F1-02D — FAIR Data Maturity Model: 'Data is identified by a globally unique identifier' · FsF-F1-02D — F-UJI/FAIRsFAIR: 'Data is assigned a persistent identifier'
“Stocks for mutations chosen for public distribution may be obtained from the Bloomington Drosophila Stock Center or the Department of Drosophila Genomics and Genetics Resources of the Kyoto Institute of Technology as indicated in Supplementary Table 6.”— not found in the paper; verdict downgraded
The paper names two repositories (Bloomington Drosophila Stock Center and Kyoto Institute of Technology) as holders of the biological stocks, which are part of the study's output. [downgraded to 'partial' — no verifiable quote from the paper] [majority verdict 'partial' (4/5 passes agreed)]
RDA-F4-01M — FAIR Data Maturity Model: metadata is offered so it can be harvested and indexed ( · NIH DMS Policy Element 4 (NOT-OD-21-014) — name the repository where data will be archived · NSTC Desirable Characteristics of Data Repositories (2022) — 'Long-Term Sustainability', 'Reten
No identifier for the dataset appears anywhere in the paper; the article DOI is not the data's identifier.
FORCE11 Joint Declaration of Data Citation Principles (2014) — data should be cited as a first- · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes · FsF-F3-01M — F-UJI: 'Metadata includes the identifier of the data it describes'
Advisory · not in the published score
“The accompanying tables contain complete mutation-characterization data. Stocks for mutations chosen for public distribution may be obtained from the Bloomington Drosophila Stock Center or the Department of Drosophila Genomics and Genetics Resources of the Kyoto Institute of Technology as indicated in Supplementary Table 6.”— not found in the paper; verdict downgraded
The statement points to supplementary tables within the article (Colavizza category 2) and to stocks from repositories; the primary dataset (mutation data) is in the article. [downgraded to 'no' — no verifiable quote from the paper] [majority verdict 'no' (4/5 passes agreed)]
Colavizza, Hrynaszkiewicz, Staden, Whitaker & McGillivray (2020), 'The citation advantage of li · Springer Nature research data policy — Data Availability Statements: standard statement templat · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes
“Supplementary Table 5 describes the mutations”
The paper includes a supplementary table (itemised inventory) that describes the mutation data, fulfilling the requirement for a structural description.
RDA-F2-01M — 'Rich metadata is provided to allow discovery' (priority Essential) · FsF-F2-01M — F-UJI: 'Metadata includes descriptive core elements to support data findability' · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data'
“The accompanying tables contain complete mutation-characterization data.”
The data are presented in the article's tables, which are openly accessible under the article's license, with no stated precondition. [majority verdict 'yes' (4/5 passes agreed)]
RDA-A1.1-01D — 'Data is accessible through a free access protocol' · FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · NSTC Desirable Characteristics of Data Repositories (2022) — 'Free and Easy Access'
Advisory · not in the published score
“This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.”
The paper labels the article as Open Access with a CC-BY license, but this label applies to the article, not explicitly to the data; no separate access level label is stated for the dataset itself. [majority verdict 'no' (4/5 passes agreed)]
FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · RDA-A1-01M — metadata contains information to enable the user to get access to the data · COAR Controlled Vocabularies — Access Rights v1.0 (open / embargoed / restricted / metadata-onl
“Stocks for mutations chosen for public distribution may be obtained from the Bloomington Drosophila Stock Center or the Department of Drosophila Genomics and Genetics Resources of the Kyoto Institute of Technology as indicated in Supplementary Table 6.”— not found in the paper; verdict downgraded
The data are not sensitive; stocks are publicly available from repositories with no named gatekeeper; no institutional or personal gatekeeper is specified.
NIH Genomic Data Sharing Policy (NOT-OD-14-124) — controlled-access via a Data Access Committee · RDA-A1.2-01D — 'Data is accessible through an access protocol that supports authentication and · NIH DMS Policy Element 5 (NOT-OD-21-014) — Access, Distribution, or Reuse Considerations (conse
No sentence states when the data become available or how long they persist; only that stocks may be obtained from repositories. [majority verdict 'no' (3/5 passes agreed)]
NIH DMS Plan Element 4 (NOT-OD-21-014) — Data Preservation, Access, and Associated Timelines · NSTC Desirable Characteristics (2022), Organizational Infrastructure: 'Retention Policy' · RDA-A2-01M — 'Metadata is guaranteed to remain available after data is no longer available'
No file format is named for the released data; the supplementary tables are assumed to be part of the article but no format token is provided.
FsF-R1.3-02D — F-UJI: 'Data is available in a file format recommended by the target research co · RDA-R1.3-02D — data is expressed in a machine-understandable community standard · RDA-I1-01D — data uses a knowledge representation expressed in a standardised format
Advisory · not in the published score
“Gene models, annotations, and nomenclature reflect FlyBase release 2024_4.”
The paper names FlyBase release 2024_4 as a community standard for gene annotations, applied to the data. [majority verdict 'yes' (4/5 passes agreed)]
RDA-R1.3-01M — 'Metadata complies with a community standard' (priority Essential) · RDA-R1.3-01D — 'Data complies with a community standard' · RDA-I2-01M — '(Meta)data use vocabularies that follow FAIR principles'
The paper does not provide any identifier (accession, DOI, RRID, etc.) for an external resource that the data depend on. [majority verdict 'no' (3/5 passes agreed)]
RDA-I3-01M — '(meta)data include references to other (meta)data' · RDA-I3-03M — 'metadata includes qualified references to other metadata' · FsF-I3-01M — F-UJI: 'Metadata includes links between the data and its related entities'
The paper only mentions the article's CC BY license (scope rule excludes it); no separate license for the data is stated. [majority verdict 'no' (3/5 passes agreed)]
RDA-R1.1-01M — 'Metadata includes information about the licence under which the data can be reu · RDA-R1.1-02M — 'Metadata refers to a standard reuse licence' · RDA-R1.1-03M — 'Metadata refers to a machine-understandable reuse licence'
No version token or date is provided for the dataset; the data are not identified by a snapshot identifier. [majority verdict 'no' (4/5 passes agreed)]
DataCite Metadata Schema 4.6 — the 'Version' property · RDA-R1.2-01M — provenance information (which version was used is provenance) · NSTC Desirable Characteristics of Data Repositories (2022) — 'Provenance', 'Retention Policy'
No code location is given; the study does not mention any code written for this work.
NIH DMS Policy Element 2 (NOT-OD-21-014) — 'Related Tools, Software and/or Code' · FAIR4RS Principles v1.0 (Chue Hong et al., 2022; RDA/FORCE11/ReSA) — FAIR Principles for Resear · FORCE11 Software Citation Principles (Smith, Katz & Niemeyer, 2016, PeerJ CS 2:e86)
“B.M.W., B.P.W., K.R.C., M.J.S., J.P.K., and S.J.N. were supported by the National Institutes of Health (NIH) grant R24 OD028242. K.R.C. was also supported by NIH grant P40 OD018537.”
The paper provides specific grant numbers (R24 OD028242, P40 OD018537) attached to the funder.
DataCite Metadata Schema 4.6 — 'FundingReference' property (funderName, funderIdentifier, award · Crossref Funder Registry — canonical funder identifiers for funding metadata · RDA-F2-01M — rich metadata provided to allow discovery (funding is part of the descriptive reco
Advisory · not in the published score
“In males, a transgene expressing Cas9 in the germ line ( nanos-Cas9 ) was combined with a transgene ubiquitously expressing a guide RNA targeting a specific fourth chromosome gene ( U6-gRNA ) and a transgene carrying an FRT sequence inserted near the base of an isogenized fourth chromosome.”
The text names specific transgenes (nos-Cas9, U6-gRNA) used to produce the mutations, which are proper-noun tools. [majority verdict 'yes' (3/5 passes agreed)]
RDA-R1.2-01M — 'Metadata includes provenance information according to community- specific standa · FsF-R1.2-01M — F-UJI: 'Metadata includes provenance information about data creation or generati · W3C PROV-O (W3C Recommendation, 2013) — the entity/activity/agent model of provenance
“Supplementary Table 5 describes the mutations”
The mutation data are described within a supplementary table in the article, not in a separate documentation object shipped with the data.
RDA-R1-01M — '(Meta)data are richly described with a plurality of accurate and relevant attribu · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data' · NIH DMS Policy Element 3 (NOT-OD-21-014) — Standards (documentation and metadata to accompany t
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R24 OD028242
National Institutes of Health
Grant: P40 OD018537
NHGRI NIH HHS
Grant: U24 HG013300
FWCI
0.38
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords